Navigation Links
Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes
Date:11/15/2012

SAN FRANCISCO, Nov. 15, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that it has awarded $80,000 in sponsorships to four San Francisco community organizations. The San Francisco sponsorships are part of the nationwide Novo Nordisk Community Care initiative to help rally communities to address the diabetes crisis and support local programs designed to make an impact for people living with type 2 diabetes. According to data commissioned by Novo Nordisk from the Institute of Alternative Futures, as of 2010, San Francisco had more than 433,000 people with diagnosed and undiagnosed diabetes and an additional 1.1 million people in danger of developing diabetes.

Novo Nordisk convened two community leaders to help evaluate the many innovative programs that were presented for sponsorship – Marlene Bedrich, RNC, MS, CDE at the Diabetes Teaching Center at UCSF and Jeffrey Manese, Physician Assistant at the Kapla Medical Group. Programs that received funding were considered to be the most creative, impactful, and meaningful for the community and took an innovative approach to addressing type 2 diabetes.     

"We know from research that type 2 diabetes has far-reaching impact in San Francisco and that local organizations play a critical role in addressing the problem through programs that understand the local population," said Bedrich. "By providing support to incubate innovative programs on a local level, Novo Nordisk is providing an important resource to help address the diabetes epidemic in San Francisco."

Organizations that received sponsorships target a range of diverse communities in San Francisco and include:

  • Dance Out Diabetes – They will expand their "Dance Out Diabetes Cash and Care for Wellness" program with new diabetes education workshops and dance offerings in San Francisco County communities.
  • LIFT – Levantate – Through the sponsorship, their Adult Diabetes Management Project will offer diabetes education to multicultural populations and train community health advocates in Bay Area communities such as Marin City, Novato, the Canal area of San Rafael, San Francisco (Portola), Richmond, and San Leandro.
  • Northern California Center for Well-Being – Their "Live Well Type 2 Diabetes Peer Mentor" program will train peer mentors to serve as health coaches and teach people living with diabetes how to properly manage the disease.
  • North East Medical Services – NEMS will offer Stanford University Patient Education Center's "Diabetes Self Management Program" in various Chinese languages at its seven area clinics.

"Novo Nordisk is proud to partner with each of these San Francisco organizations for their innovative approach to diabetes education in their local community," said Lori Moore, Executive Director of Communications and Public Affairs at Novo Nordisk. "It is our hope that through Community Care, Novo Nordisk can help local organizations around the country develop impactful programs that will have a lasting effect on the epidemic of type 2 diabetes."

In 2011, Novo Nordisk Community Care sponsored more than 20 diverse community-based programs and awarded $415,000 to organizations in Atlanta, Minneapolis, Boston, and Philadelphia. In addition to San Francisco, in 2012, Novo Nordisk is offering new sponsorship opportunities to eligible organizations in the Houston, Detroit, and Milwaukee/Madison metropolitan areas where diabetes is a heavy burden on the community. In these areas, the Novo Nordisk Community Care initiative aims to activate and enable organizations that are ambassadors for change in diabetes care and are making an impact in their local communities. For more information about Novo Nordisk Community Care, visit www.novonordisk-us.com/communitycare.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone replacement therapy. For more information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
2. Novo Nordisk Supports Three Houston-Based Organizations In Fight Against Diabetes
3. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
4. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
7. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
8. Ventana Supports World Patient Safety Day, July 25
9. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
10. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
11. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2017)... Aug. 31, 2017 PM360,s annual Innovations ... to the latest innovations happening across the industry. Established ... to focus on providing a comprehensive look at the ... covers the most innovative companies, startups, divisions, products, services, ... "Everyone in this industry wants to ...
(Date:8/29/2017)... 2017 In a move that promises to ... for veterinary practices of all sizes, Cubex LLC and ... makes TITAN,s expertise in physical security, drug diversion investigations, ... nationally. "Every ... substances is at risk today," said TITAN founder and ...
(Date:8/28/2017)... , Aug. 28, 2017   Aesculight ®, a division of ... surgical lasers. Built on over 20 years of American veterinary laser ... New and Exclusive VetScalpel®Features and Enhancements ... Duclos, DVM, is excising a tumor with his new VetScalpel laser. Dr. ... Lynnwood, WA. ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “Monique”: is the ... situations. “Monique” is the creation of published author, Colleen Crispi, has owned four beauty ... Crispi has been involved in real estate and cooking. , “The doctor’s office ...
(Date:9/19/2017)... ... ... Only a few physicians were selected to receive the prestigious 2016 Patients' Choice ... . The founder and medical director of Clevens Face and Body Specialists , ... and the University of Michigan. He has served patients throughout Central Florida and beyond ...
(Date:9/19/2017)... ... 2017 , ... PAPA Healthcare, Inc. announced today, the release ... helps fill gaps, provide essential insights, and improve productivity.” The story focuses ... PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s Home Infusion provides ...
(Date:9/19/2017)... ... 19, 2017 , ... Peter Chandonait, Abt Associates Principal Scientist ... (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named the Grand ... Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners who ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to Texas as a part of its national Swirl: A Wine Tasting ...
Breaking Medicine News(10 mins):